Technomark News: December 2020

Tuesday, December 15, 2020

Alzheimer’s Drugs Market to Register Unwavering Growth During to 2030 – AC Immune, F. Hoffmann-La Roche, DAIICHI SANKYO

For patients suffering from the Alzheimer’s disease, there are no treatments or alternative those completely cure it. But, there are treatments that efficiently improve the symptoms of memory loss and issues associated with reasoning and thinking. The available treatments for the said disease considerably enhance the functioning of chemicals in the patient brain that transfer information from one brain cell to another brain cell. Yet, these treatments prevent stoppage to the underlying decline and destruction of the brain cells. Also, with the death of more brain cells, the disease continues its progression. Hence, experts are carefully positive for developing the treatment that can considerably stop the delay of the progression of the disease.

Alzheimers Drugs market was estimated to be over US $ 3.5 Bn in 2018. It is anticipated to grow at a CAGR of 7.2% from 2019 to 2030.

Growing prevalence rates of Alzheimers disease globally and rising geriatric population worldwide is anticipated to fuel the growth of Alzheimers drugs market. With the globally increasing ageing population, the number of patients suffering from Alzheimers disease is projected to grow during the forecast period. According to the World Health Organization (WHO) between the years 2015 and 2050, the proportion of the worlds population over 60 years will nearly double from 12% to 22%. It is estimated that dementia affects 46.8 million people worldwide with an estimated cost of USD 818 billion. Alzheimers disease is the most common cause of dementia, with 9.9 million people newly diagnosed with dementia each year. Unfortunately there is no cure for Alzheimers, which has become one of the greatest public health challenges globally. These factors are expected fuel the Alzheimers Drugs Market in the forecast period. Current treatments focus on delaying the onset of the disease and on alleviating the symptoms, however they are unable to stop the disease from progressing as they do not alter or affect the underlying causes.

Major Key Players of the Alzheimer’s Drugs Market are:
AC Immune, F. Hoffmann-La Roche, DAIICHI SANKYO COMPANY, Eli Lilly and Company, H. Lundbeck A/S, Eisai Co., Avanir Pharmaceuticals, Inc., Novartis AG, Janssen Global Services, LLC, AbbVie Inc. among others.

Cosmetic Lasers Market to Witness an Outstanding Growth during 2020 – 2030 – Cutera, Cynosure, Alma Lasers, SharpLight Technologies

Cosmetic lasers are majorly used in the dermatology field by dermatologists to cure the issues of the skin. These cosmetic lasers emit radiation through which most of the skin disorders can be reduced and eliminated. Lasers are the devices that resurface the modality of the skin, the harnesses light power and the heat in order to improve the skin tone, coloration, and texture of the patients. There are two types of lasers used in the cosmetic domain of dermatology; they include the ablative and the non-ablative that are mainly used to treat skin disorders like lines, wrinkles, sun damage, acne scars, that are greatly different.

Cosmetic lasers market is estimated to be over US$ 1,500 Mn in 2018. It is anticipated to grow at a CAGR of 13.4% from 2019 to 2030.

The continual growth of the cosmetic lasers market can be attributed to several factors which have led to wide scale adoption of these products which are extensively used to improve physical appearance of patients. Moreover, the growing demand for cosmetic treatments and therapies across the globe is anticipated to further contribute to the substantial growth of the global cosmetic lasers market between 2019 and 2030. To obtain better insights regarding the market scenario prominent players are increasingly focusing on collaborative initiatives with several institutes and research centers. The Anglia Ruskin University, based in England, has entered into an agreement with Allergen Inc., a cosmetic lasers company, to develop educational program for practicing physicians in the Asia Pacific region on facial aesthetics.

Major Key Players of the Cosmetic Lasers Market are:
Cutera, Cynosure, Alma Lasers, SharpLight Technologies, Aerolase, Syneron Medical, Sciton, Solta Medical, Lumenis Ltd and El.En. S.P.Aamong others.

Medical Device Contract Manufacturing Market Size, Competitive Strategies, Application Analysis, Regional, and Forecasts 2019 To 2030

Medical device contract manufacturing is the procedure in which the manufacturing company manufactures medical devices of essential components of medical devices. These manufactured devices are then sold by other companies. The contract manufacturers of such medical devices more often specialize in special or monotonous process of functions and can offer better experience through standard manufacturing process. The resources for the inventors or manufacturers of the medical devices comprise the product design, its development, testing, process validation, manufacturing, or also superior quality packaging. The medical device (Original Device Manufacturer) OEMs is the companies that focus on specialized area of expertise for the manufacturing of medical device like research and development, assembly, or molding.

Medical device contract manufacturing market is estimated to be over US$ 48 Bn in 2017. It is anticipated to grow at a CAGR of 8.5% from 2019 to 2030.

The global medical device contract manufacturing market is driven by focus of market players in introducing new and innovative products, rising geriatric population, need for cost effective products, rising cost for hospitals and increasing demand for medical devices are some of the major factors driving the market. Moreover, Polymer Science and Engineering Department of the University Of Massachusetts (UMASS) are offering several programs to enhance medical device industry and help to generate skilled workers. However, high cost of medical devices and stringent government policy related to medical device manufacturing is likely to restrain the market to certain extent.

Major Key Players of the Medical Device Contract Manufacturing Market are:
Flextronics International, Benchmark Electronics, Jabil Inc., Integer Holdings Corporation (Greatbatch), West Pharmaceutical Services, Inc., Tecomet, Inc., Nortech Systems, TE Connectivity (Creganna Medical), Forefront Medical Technologies, Nordson Corporation and other prominent players.

Blood Collection Market Outlook to 2030: Emerging Trends and Will Generate New Growth Opportunities Status

Blood collection is a medical process that saves lot of time and offers doctors to immediately deliver and monitor the diseases. Blood collection samples process is a regularly used technique to track the severe as well as mild diseases. Earlier, the collection of blood was a painful and a time-consuming procedure. Hence, the improved blood collection method used today overcomes all of the above mentioned challenges. Blood collection and its results help reveal the medical condition of the patient, his overall condition, and disclose more about specific conditions. A normal health checkup generally comprises blood collection, which is essential and a beneficial tool to control and regulate the medical condition of the patient.

Blood collection market accounted forover US$ 8.9 billion in 2019. It is anticipated to grow at a CAGR of ~5.2% from 2020 to 2030.

The first step in acquiring a quality lab test result for any patient is the specimen collection or blood collection procedure. The global blood collection market is growing at a stable pace and is expected to continue growing steadily during the forecast period. The factors which can be attributed to the growth of this market are rising incidences of accidents & trauma cases globally, increasing cases of ailments that require blood diagnosis, initiatives by both private & public bodies to promote blood donations, rising demand for blood components, among others. However, factors such as the outbreak of infectious diseases, such as the current global COVID-19 pandemic, is expected to hamper the growth of this market immensely.

The prominent players operating in the global blood collection market are:
Terumo Medical Corporation, Medtronic, BD, Fresenius Kabi AG (Fresenius Health Care Group), Grifols, S.A., FL MEDICAL s.r.l., Haemonetics Corporation, Greiner Bio One International GmbH, Smiths Medical (Smiths Group plc.), KAWASUMI LABORATORIES. INC., among others.

Vitamin D Market Size, Competitive Strategies, Application Analysis, Regional, and Forecasts 2019 To 2030

Vitamin D market accounted for over US$ 1.0 billion in 2019. It is anticipated to grow at a CAGR of ~6.5% from 2020 to 2030.

Vitamin D enables calcium absorption in the gut and normal mineralization of bones by balancing calcium & phosphate concentrations. It is an essential component for bone growth and bone remodeling and its deficiency may lead to serious medical conditions such as brittleness of bones, osteoporosis, osteomalacia, hypocalcemia, rickets, cardiovascular diseases, cancer, autoimmune diseases, and asthma. Modulating the cell growth, thyroid functions, neuromuscular functions, & immune functions; regulating the blood circulation & blood clotting; and reducing inflammation are some of the other key functionalities that vitamin D carries out.

Major Key Players of the Vitamin D Market are:
Dishman Group, Divi’s Nutraceutical, Stabicoat Vitamins, Lycored, Bio-Tech Pharmacal, Kingdom Nutrition Inc., New Gen Pharma Inc., Koninklijke DSM N.V., BASF, and Tocris Bioscience, among others.

COVID-19 Diagnostics Market Segmentation Application, Technology and Market Analysis Research Report to 2030

COVID-19 or Coronavirus is the novel disease that initialed from Wuhan, China and is infecting humans, especially the adults and elders. The pandemic began in late 2019 years and is still prevailing in most key regions across the globe with rising number of cases each day and has hampered several crucial businesses activities and created high level of panic among businesses as well as the general public. The novel Coronavirus majorly causes mild respiratory disease, severe acute respiratory syndrome Coronavirus (SARS-CoV), and the zoonotic Middle East respiratory syndrome (MERS-CoV) having comparatively higher death rates, worldwide. The WHO (World Health Organization) is constantly examining the available immunodiagnostic tests for the said infection.

The prominent players operating in the global COVID-19 diagnostics market are:
Seegene Inc., F. Hoffmann-La Roche Ltd, altona Diagnostics GmbH, SD BIOSENSOR, Abbott, BIOMEDOMICS INC., Bio-Rad Laboratories, Inc., VivaChek Biotech (Hangzhou) Co., Ltd., Sensing Self, PTE. Ltd, Thermo Fisher Scientific, PerkinElmer Inc., among others.

Vinyl Chloride Monomer (VCM) Market Report with Key Vendors, Driver, Challenges & Trends, Vendor Landscape Analysis & Forecast 2019 to 2030

Vinyl chloride monomer (VCM) market in terms of volume was over 52 million tons and is anticipated to grow at a CAGR of 6.3% from 2019 to 2030.

Rising demand from end-use industries such as construction, healthcare, and agriculture is the prime factor driving the market growth. Production of bio-based VCM is anticipated to boost the overall market demand. VCM market is witnessing growth owing to increasing demand of PVC from end use industries. Construction and health care are the two major industries.

Major Key Players of the Vinyl Chloride Monomer (VCM) Market are:
Occidental Petroleum Corporation, Dow, Formosa Plastics Corporation, AGC Chemicals, Vynova Group, Westlake Chemical Corporation, Solvay, Sasol, DuPont, SP Chemicals Holdings Ltd.

Nitroparaffin Market Research Report: Size, Share, Growth, Trends and Forecast 2030 – Aceto Corporation, ANGUS Chemical Company

Nitroparaffin market was valued at US$ 31.6 Bn by 2019. The market is anticipated to grow at a CAGR of 0.48% from 2019 to 2030.

The growth of the global nitroparaffin market can be attributed to several factors such as increasing use of nitroparaffin as a solvent, fuel & fuel additive and the rising demand for nitroparaffin in agrochemical products. However, according to the International Agency for Research on Cancer (IARC), nitroparaffin is classified as a possible carcinogen for humans, which may hamper the market growth to a certain extent. The favorable regulations in emerging countries pertaining to the use and production of the nitroparaffin are helping local SMEs to use nitroparaffin derivatives in various end-use industries such as pharmaceutical, chemical, paint & coating, agriculture, and others.

Major Key Players of the Nitroparaffin Market are:
Aceto Corporation, ANGUS Chemical Company, Linyi Yuanbo Chemical Co., Ltd., SynQuest Laboratories, Zhanhua Binbo Chemical Co., Ltd.

Medical Nutrition Market Size, Competitive Strategies, Application Analysis, Regional, and Forecasts 2017 To 2026

Medical Nutrition Market is accounted for $35.92 billion in 2017 and is expected to reach $70.62 billion by 2026 growing at a CAGR of 7.8% during the forecast period. Increasing malnutrition cases associated with chronic diseases, approvals of novel parenteral nutrition combinations and premature birth and aging health-conscious population are some of the factors fuelling the market growth. However, Side-effects or Complications related to parenteral nutrition products is restricting market growth.

Major Key Players of the Medical Nutrition Market are:
Sichuan Kelun Pharmaceutical Company Limited, Sanofi, Perrigo Company plc, Otsuka Pharmaceuticals Co., Ltd., Nutricia, Nestlé S.A., Mead Johnson Nutrition, Lonza Ltd., Hospira Inc., Fresenius SE & Co. KGaA, Danone Nutricia, Baxter International, B. Braun Melsungen AG, Allergan and Abbott Nutrition.

Healthcare Contract Management Software Market Segmentation Application, Technology and Market Analysis Research Report to 2026

Healthcare Contract Management Software market accounted for $ 528.70 million in 2017 and is expected to reach $ 2627.37 million by 2026 growing at a CAGR of 19.5 % during the forecast period. Some of the key factors such as high returns on investment and growing need for healthcare insurance providers are driving the market growth. However, the high costs involved for the implementation of this software and IT infrastructural limitations in developing countries are the restraining factors for the market growth. Moreover, competitive rivalry among healthcare payers and declining reimbursements will provide ample opportunities for the growth of the market.

Major Key Players of the Healthcare Contract Management Software Market are:
Concord, Determine Inc., Icertis Inc., Optum Inc., CobbleStone Software, Coupa Software Inc., nThrive Inc., Experian PLC., Contract Logix LLC., ScienceSoft and Apttus Corporation.

Monday, December 14, 2020

Immunity Nutraceutical Ingredient Market Outlook to 2026: Emerging Trends and Will Generate New Growth Opportunities Status

Immunity Nutraceutical Ingredient Market is growing at a CAGR of 7.4% during the forecast period. Increasing demand for fortified food owing to the rising health consciousness among people and mandates on food fortification by government associations are some of the factors fuelling the market growth. However, higher costs of fortified products preventing large-scale usage are restraining the market growth. Nutraceutical ingredients are derived from sources such as animal, plant, microbial, and synthetic, which provide health benefits, adding the basic nutritional value and functional benefits to various applications such as food, beverages, dietary supplements, animal nutrition, and personal care products.

Major Key Players of the Immunity Nutraceutical Ingredient Market are:
Tate & Lyle PLC (U.K), Koninklijke DSM N.V., Ingredion Incorporated (U.S), Arla Foods (Denmark) and Ajinomoto Co., Inc. (Japan).

Legal Marijuana Market Size, Competitive Strategies, Application Analysis, Regional, and Forecasts 2017 To 2026

Legal Marijuana Market is accounted for $12.78 billion in 2017 and is expected to reach $75.69 billion by 2026 growing at a CAGR of 21.9% during the forecast period. Some of the key factors influencing the market growth include Growing legalization in various countries and rising adoption of cannabis as a medical product for treating conditions such as Parkinson’s disease, cancer, arthritis, and neurological disorders. However, stringent rules and regulations regarding the product sale and cultivation is restraining the market growth.

Major Key Players of the Legal Marijuana Market are:
Cannabis Sativa, Inc., Aphria, Inc., GW Pharmaceuticals, plc., Maricann Group, Inc., United Cannabis Corporation., Canopy Growth Corporation., Tikun Olam, Ltd., Tilray, Aurora Cannabis, Lexaria Corp., The Cronos Group, Organigram Holding, Inc. and ABcann Medicinals, Inc.

Patient Care Monitoring Systems Market Research Analysis, Emerging Opportunities, Costs Involved in Setting up The Implementations 2026

Patient Care Monitoring Systems is accounted for $17.41 billion in 2017 and is expected to reach $33.95 billion by 2026 growing at a CAGR of 7.7% during the forecast period. Increasing incidence of chronic diseases and the growing availability of wireless monitoring devices and for eco-friendly packaging are the major factors boosting the market growth. Moreover, the demand for extended shelf-life of products will create ample opportunities for market growth. However, high capital investments for manufacturing may hinder the growth of the market.

Major Key Players of the Patient Care Monitoring Systems Market are:
Bosch Medical, Cardiocom, GE Healthcare, Honeywell HomMed, Omron Healthcare, Philips Healthcare, Abbott Laboratories, AMD Global Telemedicine, Carematix, Coviden, Mindray, OSI Systems, Welch Allyn, Second Opinion Telemedicine Schiller AG and Roche.

Biochips Market Segmentation Application, Technology and Market Analysis Research Report to 2025

Biochip is a miniaturized medical device, which performs several biochemical reactions. This device is a collection of microarrays or micro-test strips that are arranged on the surface of chip, and are meant to perform multiple tests simultaneously. Biochip is extremely small in size ranging from 2 inches to 12 inches. These chips can perform various biotechnology applications such as decoding genes and searching for contaminations in the sample in a few seconds.

Major Key Players of the Biochips Market are:
bioMérieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Fluidigm Corporation, HORIBA, Ltd., Illumina, Inc., PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., Thermo Fisher Scientific Inc.

In Vitro Diagnostics (IVD) Market by Product, Demand, Growth, Strategic Opportunities and Leading Players Forecast To 2025

In vitro diagnostics (IVD) market was valued at $64,479 million in 2017, and is estimated to reach at $93,614 million by 2025, registering a CAGR of 4.8% from 2018 to 2025.

In vitro diagnostic (IVD) is a technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues, and other body fluids, which are derived from the human body to detect diseases, conditions, and infections. The tests can be performed in stand-alone laboratory, hospital-based laboratory, and point of care. Some of the significant technologies incorporated in IVD include polymerase chain reaction (PCR), microarray techniques, sequencing technology, and mass spectrometry, which are used for test sample preparation. Incessant innovations in IVD product type design and technology have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines.

Major Key Players of the In Vitro Diagnostics (IVD) Market are:
Abbott Laboratories; Becton, Dickinson and Company; bioMérieux SA, Bio-Rad Laboratories, Inc.; Danaher Corporation (Beckman Coulter, Inc.); F. Hoffmann-La Roche Ltd.; Johnson & Johnson; QIAGEN N.V.; Sysmex Corporation; and Thermo Fisher Scientific, Inc.

K-beauty Products Market Detailed Insights on Upcoming Trends 2019 – 2026 – Bluehug, BNH Cosmetics

Despite the dominance of western cosmetics giants, the South Korean brands are gradually setting novel standards of beauty, driven especially by the global popularity of K-pop. A large number of people, irrespective of their gender, are capitalizing on beauty products originated from South Korea. K-beauty products are manufactured using exceptional ingredients, which result into unique and desirable looks. For instance, the k-beauty products include raw materials derived from snail slime, bee venom, starfish extract, pig collagen, and morphing masks. The K-beauty industry is thereby progressively fetching a lucrative business for cosmetic companies owing to its high product margin, hence making it further profitable for beauty companies.

Major Key Players of the K-beauty Products Market are:
ABLE C&C CO., Ltd., Adwin Korea Corp, Annie’s Way International Co., Ltd., The Beauty Factory, Ltd., Bluehug, Inc., BNH Cosmetics, Ceragem Health and Beauty Co, Ltd., CK Beauty Enterprise Inc., F&Co. Co., Ltd., LG Household & Health Care, and AMOREPACIFIC CORPORATION.

Biopharmaceuticals Market Size, Competitive Strategies, Application Analysis, Regional, and Forecasts 2019 To 2025

Biopharmaceuticals are drugs having a biological origin. These large and complex drugs, which often comprise heterogeneous mixtures, are produced using biotechnology and usually from genetically engineered cells. The global biopharmaceuticals market accounted for $186,470 million in 2017, and is projected to reach $526,008 million by 2025, registering a CAGR of 13.8% from 2018 to 2025.

Major Key Players of the Biopharmaceuticals Market are:
Abbott Laboratories, Amgen, Inc., Biogen, Inc., Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Pfizer, Inc., Sanofi

Donor Egg IVF Services Market Is Expected To Grow Tremendously By 2025 – Virtus Health, Monash IVF Wesley Hospital Auchenflower, Fertility First

In vitro fertilization is an assisted reproductive technology (ART), which involves retrieving eggs from a woman’s ovaries and fertilizing them with sperms outside the body, that is, in vitro. The donor egg IVF services market for the customized regions generated $1,668 million in 2017 and is projected to reach $3,290 million by 2025, growing at a CAGR of 8.8% from 2018 to 2025.

Major Key Players of the Donor Egg IVF Services Market are:
Virtus Health, Monash IVF Wesley Hospital Auchenflower, Fertility First, Flinders Reproductive Medicine Pty Ltd., Fertility Associates, Genea Oxford Fertility Limited, Repromed, SAFE Fertility Center, Bangkok IVF Center (Bangkok Hospital), Bangkok IVF Center, Damai Service Hospital, TMC Fertility Centre, KL Fertility & Gynecology Centre, Bourn Hall Fertility Center, Southend Fertility and IVF, Morpheus Life Sciences Pvt. Ltd., Bloom Fertility Center, Cloudnine Fertility, Chennai Fertility Center, Shanghai Ji Ai Genetics & IVF Institute, Shanghai United Family Hospital, IVF NAMBA Clinic, Sanno Hospital, Thomson Medical Pte. Ltd., Raffles Medical Group, TRIO Fertility, The Montreal Fertility Center, Procrea Fertility, IVF Canada, Sims IVF, Merrion Fertility Clinic, Beacon CARE Fertility, Medfem Fertility Clinic, The Cape Fertility Clinic, Aevitas Fertility Clinic

DNA Sequencing Market Size, Competitive Strategies, Application Analysis, Regional, and Forecasts 2019 To 2025

DNA sequencing is a molecular technique that helps determine the nucleotide sequence of DNA (deoxyribonucleic acid), which is the most fundamental level of knowledge of a gene or genome. The global DNA sequencing market accounted for $6,243 million in 2017, and is anticipated to reach $25,470 million by 2025, registering a CAGR of 19.0% from 2017 to 2025. DNA sequencing has revolutionized molecular biology and genomics research. The knowledge of DNA sequences of genes and other parts of the genome of organisms has become essential for life-science research and also in applied fields, such as forensics, cancer diagnostics, and others. Through this method, billions of DNA strands can be sequenced efficiently. DNA sequencing has made it possible to conveniently sequence whole genomes and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. They are utilized through varied interventions, such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.

Major Key Players of the DNA sequencing Market are:
Abbott Laboratories, Agilent Technologies, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd, Illumina, Inc, LI-COR Biosciences, Inc., Pacific Biosciences of California, Inc., SIEMENS AG; PerkinElmer Inc., Thermo Fisher Scientific, Inc.

Oncology Information Systems Market Is Expected To Grow Tremendously By 2025 – Accuray Incorporated, Bogardus Medical Systems

Oncology information systems market was valued at $2,622 million in 2017, and is estimated to reach $4,569 million by 2025, registering a CAGR of 7.1% from 2018 to 2025.

Patient portfolios are managed by software termed as oncology information systems across the healthcare settings, such as clinics, hospitals, and research laboratories. In addition, this software are used to predict treatment outcomes, plan the patient’s treatment accordingly, and exchange cancer patient information among the overall healthcare organizations. These advantages improve the safety and efficiency of cancer therapy for patients. Oncology information systems help physicians and surgeons to choose the most appropriate therapy to improve the survival rate of the cancer patients. The availability of a variety of cancer therapies, such as chemotherapy and radiation therapy, and presence of huge cancer population base are the major factors that drive the market growth.

Major Key Players of the Oncology Information Systems Market are:
Accuray Incorporated, Bogardus Medical Systems, Inc., Cerner Corporation, CureMD Corporation, Elekta AB, Flatiron Health, Inc., Koninklijke Philips N.V., McKesson Corporation, RaySearch Laboratories AB, Varian Medical Systems, Inc.

Thursday, December 10, 2020

Centesis Catheters Market 2020 Market Size & Growth Rate, Emerging Trends, Main Vendors, and Forecasts 2030

Centesis catheters market accounted for over approximately US$ 430 million in 2019. It is anticipated to grow at a CAGR of 6.3% from 2020 to 2030.

The growth of the centesis catheters market can be attributed to several factors such as increasing incidence of target neurological conditions. Moreover, a growing number of clinical research activities for minimally invasive cancer treatment and a rising preference for minimally invasive procedures across the globe are anticipated to further contribute to the global centesis catheters market growth between 2019 and 2030. Additionally, increasing government awareness for improving emergency care infrastructure, coupled with the increasing use of advanced technology in emergency care, is anticipated to further promote the growth of the centesis catheters market during the forecast period.

Major Key Players of the Centesis Catheters Market are:
Medtronic, Teleflex Incorporated, Smiths Group plc., AngioDynamics, B. Braun Melsungen AG, Becton, Dickinson, and Company, Boston Scientific Corporation, Cardinal Health, Cook Medical, and Merit Medical Systems, among others.

Animal Parasiticides Market Share, Competitor’s Analysis, Supply and Consumption 2019 Research Report Forecast To 2030

Animal parasiticides market accounted for over US$ 9.2 billion in 2019. It is anticipated to grow at a CAGR of ~7% from 2020 to 2030.

Companies are increasingly engaging in business development strategies, such as acquisitions, mergers, and agreements, to expand their animal parasiticides product portfolio. For instance, in August 2020, Merck Animal Health completed the acquisition of worldwide rights to VECOXAN (diclazuril) from Elanco Animal Health. It is an oral suspension and helps in the prevention of coccidiosis in calves and lambs. Similarly, companies are aiming at developing and launching new animal parasiticides products in the market. For instance, in February 2020, Norbrook Inc. launched Selarid (selamectin), a topical parasiticide for companion animals. It is a prescription treatment for protecting cats & dogs from heartworms, fleas, ear mites, and several other pests.

Major Key Players of the Animal Parasiticides Market are:
Intervet Inc. (Merck & Co. Inc.), Ceva, Zoetis, Boehringer Ingelheim International GmbH, Chanelle Pharma Group, Abbey Animal Health Pty Ltd, Bimeda, Inc., Norbrook, Vetoquinol S.A., Virbac, and Elanco among others.

Analytical Standards Market Size, Competitive Strategies, Application Analysis, Regional, and Forecasts 2020 To 2030

Analytical standards was valued at US$ 1,367.8 million in 2019. It is anticipated to grow at a CAGR of 6.9% from 2020 to 2030.

The growth of the analytical standards market is attributed to several factors such as stringent environmental regulation, government initiatives promoting analytical testing, and the development of the pharmaceutical sector, among others. Companies are launching new analytical standards for a diverse range of industry verticals such as pharmaceuticals, food & beverage, petrochemicals, and forensics, among others. For instance, in September 2018, Honeywell launched a new portfolio of high-quality Fluka analytical standards, intended for utilization in analytical chemistry applications in Europe. Moreover, companies are focusing on developing new research facilities, which further contribute to market growth. For instance, in July 2020, Merck KGaA announced building a new US$ 21.3 Million laboratory facility in Buchs, Switzerland to support the company’s rapidly growing reference materials business. The new facility will enhance the efficiency of research & development, analytical production, and quality control.

Major Key Players of the Analytical Standards Market are:
Agilent Technologies, Inc., Merck KGaA, AccuStandard, Inc., Thermo Fisher Scientific, PerkinElmer Inc., LGC Limited, Restek Corporation, Cayman Chemical, Chiron AS, and Mallinckrodt, among others.

Hearing Aids Market Size and Growth 2019 To 2030 – Sonova, William Demant Holding, GN Store Nord

Hearing aids are the medical devices that are specially designed to be as small to be fitted in the ears of the individuals that have issues in hearing properly or clearly or are completely not able to her. These medical devices are manufactured in a way that improves the hearing ability of the individual with hearing loss problem through making the sound audible to the patient. The hearing aids are categorized as medical devices in several nations and are regulated by their respective norms and policies. The smaller audio amplifiers like PSAPs or any other plain sound reinforcing systems are not allowed to be sold as hearing aids.

Hearing aids market is estimated to be over US$ 6.5 Bn in 2017. It is anticipated to grow at a CAGR of 6.6% from 2019 to 2030.

Increasing incidences and prevalence of hearing loss, rising geriatric population has led to focus of market players in introducing new and innovative products and availability of favorable government regulations are some of the growth factors in the hearing aids market. Moreover, various educational and research institutes, organizations and societies are working on treatments of hearing losses to make the entire treatment procedure affordable. For instance, China Southeast University Institute of Life Sciences announced collaboration for joint research project with Boehringer Ingelheim, a leading pharmaceutical company.

Major Key Players of the Hearing Aids Market are:
Sonova, William Demant Holding A/S, GN Store Nord A/S, Cochlear Ltd., Sivantos Pte. Ltd., Starkey, WIDEX A/S, SeboTek Hearing Systems, Audina Hearing Instruments, Inc. and Horentek other prominent players.

Hypopigmentation Disorders Treatment Market 2019 Key Trend, Future Opportunities Forecast To 2030 – ALLERGAN, SkinCeuticals International

Hypopigmentation disorders are the different types of skin disorders that may or may not cause discomfort to the patient. Hypopigmentation is the skin patches that are usually lighter than the overall skin tone of the body. A patient with this disorder has skin pigment, of his color is based on the creation of melanin substance that is present in the body. if an individual’s skin cells do not produce sufficient amount of melanin, the individual’s skin may also lighten. These impacts on the skin can appear as spots or these spots might also cover the patient’s entire body. The disruption of this melanin substance may be caused due to several environmental or genetic conditions. Hence, it is important to detect the root cause of this skin disorder prior undergoing any treatment.

Hypopigmentation disorders treatment market is anticipated to witness a substantial CAGR of 5.6% in the forecast period.

Increasing awareness among patients, technological advancements in the sector of aesthetic treatment of pigmentation related conditions, and growing geriatric population have been pivotal in dictating the growth of the hypopigmentation disorders treatment market. Moreover, increasing incidences of disorders related to hypopigmentation, namely albinism, and vitiligo is anticipated to be the major driver of the global hypopigmentation disorders treatment market between 2019 and 2030.

Major Key Players of the Hypopigmentation Disorders Treatment Market are:
ALLERGAN, SkinCeuticals International, PIERRE FABRE GROUP, Episciences, RXi Pharmaceuticals, Obagi Cosmeceuticals, and Alvogen among others

Disposable Syringes Market Trend, Strategy Analysis & Overview 2030 – Smiths Medical, Star Syringe Limited, B. Braun Medical

Disposable syringes are majorly used by the physicians or doctors to inject the medications through intramuscular or intravenous techniques for treating diseases and also by the research and development professionals. The disposable syringes are specially made up of plastic and are commonly used in medical domain as well as in veterinary science. These syringes are easy to use and are easily available in sterilized condition. They are properly cleaned, sterilized as said earlier, ready-to-use, and are also cost-effective. Hence, these disposable syringes are speedily replacing the traditional syringes and hence, their demand has considerably increased. This also reduces the risk for transmission of harmful elements from one patient to another and increases the chances of better recovery of patients.

Disposable syringes market is estimated to be over US$ 6.5 Bn in 2018. It is anticipated to grow at a CAGR of 5.1% from 2019 to 2030.

Increasing adoption of disposable syringes can be attributed to rising awareness, disposable incomes, and implementation of advanced drug delivery technologies. Moreover, rising prevalence of chronic disorders is anticipated to contribute substantially to the growth of the global disposable syringes market between 2019 and 2030. Several organizations have entered into strategic collaborations with manufacturers for research and development of efficient drug delivery techniques. For instance, PharmaJet, the drug-delivery technology company collaborated with the organization, Path, for evaluation of several drug delivery techniques and subsequently develop programs for country level immunization. However, needle stick injuries are one of the major restraining factors affecting the growth of the market. Nurses in hospitals are most likely to suffer from needle stick injuries. According to a study conducted by Shiraz University of Medical Sciences (SUMS) Iran, most of the needle stick injuries are from Hollow-bore needles and most common among nurses.

Major Players in the Disposable syringes Market
The prominent players in the global disposable syringes market are Smiths Medical, Star Syringe Limited, B. Braun Medical Inc., Baxter, TERUMO CORPORATION, Retractable Technologies, BD, Gerresheimer AG, Fresenius Kabi AG, and UltiCare among others

3D Cell Culture Market Dynamics and Forecast From 2019 – 2030 – Corning, Thermo Fisher Scientific, Merck & Co

3D cell culture is an unnatural created environment, wherein the biological cells are raised and grown or made to communicate with their nearby surroundings. This is different from the 2 dimensional environments like the Petri dish. Petri dish is a type of cell culture which differs from 3D in a way where 3 dimensional enables the cells to grow in vitro and in all the directions just like the way they would grow in ‘in vivo’. These 3dimensional cultures are raised in bioreactors, the small capsules, wherein the cells can easily grow in spheroids, or cell colonies (3D). Around 300 spheroids are cultured in one single bioreactor.

3D cell culture market is estimated to be over US$ 600.0 Bn in 2017. It is anticipated to grow at a CAGR of 19.8% from 2019 to 2030.

Rising prevalence and incidences of several diseases worldwide has triggered the need for advanced R&D scenario across all sectors of biotechnology, life sciences, pharmaceuticals and research establishments. Both public and private sectors are now focusing on new innovative techniques, ideas to obtain latest breakthroughs in the field of life sciences. According to studies, it was estimated that the total spending on R&D by mid-market biotechnology companies, witnessed an increment of approximately 18% between 2015 and 2016. Growing need to address several forms of ailments has been crucial in dictating the funding and R&D spending by governmental establishments as well as major market players and other research institutes. Increasing R&D investments and spending is anticipated to positively contribute to the growth of the global 3D cell culture market.

Major Key Players of the 3D Cell Culture Market are:
Corning, Thermo Fisher Scientific, Merck & Co., Lonza, 3D Biotek, InSphero, REPROCELL USA Inc., Nano3D Biosciences, Inc., SYNTHECON, INCORPORATED and QGel SA, Lausanne, Switzerland.

Orthobiologics Market Size, Share, Growth, Trends and Forecast 2030 – Medtronic, DePuy Synthes, Zimmer Biomet

Orthobiologics treatment helps healing procedure of different injured muscles, fractures, ligaments, tendons, and more with the help of the naturally occurring substances in the human body, known as orthobiologics. Particularly, orthobiologics comprise the growth factors, stem cells, (PRP) the platelet-rich-plasma, the conditioned serum, autologous blood, and the bone grafts. All these elements or substances are naturally occur in the body. The domain of orthobiologics is today, speedily gaining popularity and is also expanding. It allows the human body to recreate itself via countless treatment alternatives available that previously were either extremely painful or also not very effective. Hence, considering the contemporary orthobiological procedure available today, the recovery is comparatively faster and patients report returning back to their normal lives with no injury and better physical state.

Orthobiologics market was valued at over US$ 5.5 Bn. in 2017. It is anticipated to grow at a CAGR of 5.2% from 2019 to 2030.

The growth of this market can be attributed to the factors such as, increase in sports injuries and road accidents, awareness among patients & athletes, rise in obesity rate, and continuously aging population. According to the World Health Organization, 2017, fatal road accidents are the second primary cause of factures and accidental injury worldwide with almost 646000 individuals die every year around the world.

Major Key Players of the Orthobiologics Market are:
Medtronic, DePuy Synthes, Zimmer Biomet, MTF, Sanofi, Bioventus, Arthrex, Seikagaku and NuVasive among others.

Advanced Wound Care Market Prospects Outlook 2020 – 2030 and Top Key Players – Smith & Nephew, B. Braun, ConvaTec Group

Advanced wound care items are specially designed to heal the complex wound faster than as compared to the traditional techniques that look longer time. These products are essentially covered under insurance, requiring the doctor’s regulation. This includes the alginates, the hydrogels, hydrocolloids, foam dressings and film dressings. The advanced healing process includes the inflammatory stage, the fibroblastic stage, and the maturation stage, also known as the strengthening stage. Nonetheless, there are also few constraints that could slow down the healing process, such as medical conditions, hemorrhage, infection, mechanical damage, age, dryness, diet, dead skin, smoking, varicose veins, and more.

Advanced wound care market is estimated to be over US$ 8.5 Bn in 2017. It is anticipated to grow at a CAGR of 4.3% from 2019 to 2030.

Technological advancements in the sector of wound therapy, growing geriatric population and treatment coupled with increasing awareness among patients have been pivotal in dictating the growth of the advanced wound care market. Moreover, efficient treatment options for complex wounds, diabetes and associated chronic wounds and increasing expenditures on healthcare is anticipated to be the major drive the growth of the global advanced wound care market between 2019 and 2030.Furthermore, key players have extensively focused on collaborating with several educational and research institutes to amplify R&D activities and meet the overall demands of the healthcare industry. For instance, Smith and Nephew a global medical device company entered into collaboration with University of Hull, to create wound care research cluster and facilitate development of advanced R&D centers.

Major Key Players of the Advanced Wound Care Market are:
Smith & Nephew, B. Braun, ConvaTec Group, Integra LifeSciences, 3M, Cardinal Health, Medtronic, MPM Medical, Paul HARTMANN, and MiMedx Group, among others.

Next generation sequencing (NGS) Market to Witness Huge Growth from 2020 – 2030 and Key Players – Agilent Technologies, 10x Genomics, Beckman Coulter

Next generation sequencing, deep sequencing, or massively parallel sequencing are synonymous terms that are enough to describe the DNA sequencing technology. This technology has revolutionized the genomic study or research. With the help of the next generation sequencing, the overall human genome can be efficiently sequenced in just single day. On the other hand, the previously used Sanger sequencing technology that was more prominently used to decode human genome needed over the period of ten years in order to deliver the ultimate draft. Though next generation sequencing has been mostly used in genome research, it has mostly outdated the traditional Sanger sequencing method. It has not still translated in the routine practice off clinics.

Next Generation Sequencing (NGS) market is estimated to be over US$ 4.0 Bn in 2017. It is anticipated to grow at a CAGR of 18.8% from 2019 to 2030.

The continual growth in clinical application of NGS as well as sequencing of whole or targeted genomes has presented a bright prospect for the growth of global Next Generation Sequencing (NGS) market. Reduction of costs associated with sequencing has further led to wide scale application of such techniques.

Major Key Players of the Next generation sequencing (NGS) Market are:
Agilent Technologies, 10x Genomics, Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company, Eurofins Scientific, Pacific Biosciences of California, Inc., BGI, Illumina, Inc., F. Hoffmann-La Roche AG, among others.